Authors:
Ivanova, LV
Rudolph, P
Shilov, YM
Gieseler, F
Alm, P
Tareeva, IE
Proppe, D
Citation: Lv. Ivanova et al., Correlation between the expression of DNA topoisomerases I and II alpha and clinical parameters in kidney disease, AM J KIDNEY, 38(5), 2001, pp. 1026-1037
Authors:
Gieseler, F
Clark, M
Stiebeling, K
Puschmann, M
Valsamas, S
Citation: F. Gieseler et al., Pharmacokinetics of idarubicin: Intracellular events and extracellular concentrations, HEMAT BLOOD, 40, 2001, pp. 179-183
Citation: F. Gieseler, The dilemma of gastroenterological oncology: we know a lot but we still achieve too little, INT J COL R, 15(2), 2000, pp. 112-113
Authors:
Kurz, EU
Leader, KB
Kroll, DJ
Clark, M
Gieseler, F
Citation: Eu. Kurz et al., Modulation of human DNA topoisomerase II alpha function by interaction with 14-3-3 epsilon, J BIOL CHEM, 275(18), 2000, pp. 13948-13954
Citation: F. Gieseler et V. Nuessler, Apoptosis research is saving the reputation of chemotherapy - Introduction, LEUKEMIA, 13(11), 1999, pp. 1853-1853
Authors:
Gieseler, F
Bauer, E
Nuessler, V
Clark, M
Valsamas, S
Citation: F. Gieseler et al., Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage, LEUKEMIA, 13(11), 1999, pp. 1859-1863
Authors:
Nuessler, V
Stotzer, O
Gullis, E
Pelka-Fleischer, R
Pogrebniak, A
Gieseler, F
Wilmanns, W
Citation: V. Nuessler et al., Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemiacell lines, LEUKEMIA, 13(11), 1999, pp. 1864-1872
Citation: H. Stopper et al., Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?, TOX LETT, 104(1-2), 1999, pp. 103-110
Citation: M. Kessel et al., Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells, EUR J CL PH, 55(5), 1999, pp. 369-373
Authors:
Nussler, V
Pelka-Fleisc, R
Gieseler, F
Hasmann, M
Loser, R
Gullis, E
Stotzer, O
Zwierzina, H
Wilmanns, W
Citation: V. Nussler et al., In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: Studies on a human T-cell leukemia cell line and their resistant variants, LEUK LYMPH, 31(5-6), 1998, pp. 589-597